{"id":"W4379283124","doi":"10.1200/jco.2023.41.16_suppl.e21529","title":"Immune checkpoint inhibitors in cutaneous squamous cell carcinoma: A systematic review of clinical trials.","year":2023,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Nivolumab; Pembrolizumab; Internal medicine; Clinical trial; Oncology; Refractory (planetary science); Immunotherapy; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch","metaepi_broad","research_integrity"],"category_scores_codex":[0.09985302,0.000787002,0.06327002,0.0007005323,0.0000322512,0.00000892743,0.0008470393,0.002305473,0.0001055222],"category_scores_gemma":[0.2325803,0.0004755351,0.01377567,0.0009693899,0.0005342096,0.00005944153,0.0004241286,0.006188404,0.0001484492],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008002565,"about_ca_system_score_gemma":0.01144944,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004703711,"about_ca_topic_score_gemma":0.00003114226,"domain_scores_codex":[0.9157829,0.01758924,0.06404356,0.000707645,0.001277682,0.0005989272],"domain_scores_gemma":[0.860414,0.08138953,0.05519662,0.001198871,0.001084989,0.0007159481],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000627792,0.001752627,0.0003877296,0.8610435,0.001102576,0.007862386,0.00003120986,1.358719e-7,9.053817e-8,0.000003914755,0.0033607,0.1238273],"study_design_scores_gemma":[0.006193182,0.01094336,0.0003210922,0.7429035,0.02886754,0.003962561,0.00006757281,0.000001750709,8.142268e-7,0.00002437681,0.2063762,0.0003380231],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002352453,0.9858706,0.000002912285,0.000834249,0.007063986,0.004491954,0.00002645368,0.00001575862,0.001458825],"genre_scores_gemma":[0.001147702,0.9932467,0.0004242075,0.0004527812,0.003957181,0.0001263688,0.00001115437,0.0001360383,0.0004978645],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2030155,"threshold_uncertainty_score":0.9997696,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3652561846545134,"score_gpt":0.5638272574325883,"score_spread":0.198571072778075,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}